Nationwide Fund Advisors’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-242,691
| Closed | -$9.71M | – | 1834 |
|
|
2017
Q3 | $9.71M | Buy |
242,691
+171,341
| +240% | +$6.85M | 0.04% | 663 |
|
|
2017
Q2 | $3.08M | Buy |
71,350
+8,698
| +14% | +$375K | 0.01% | 1249 |
|
|
2017
Q1 | $1.96M | Sell |
62,652
-13,682
| -18% | -$428K | 0.01% | 1406 |
|
|
2016
Q4 | $1.93M | Sell |
76,334
-22,494
| -23% | -$568K | 0.01% | 1424 |
|
|
2016
Q3 | $2.44M | Sell |
98,828
-2,620
| -3% | -$64.8K | 0.01% | 1291 |
|
|
2016
Q2 | $2.07M | Buy |
101,448
+7,469
| +8% | +$152K | 0.01% | 1344 |
|
|
2016
Q1 | $1.43M | Sell |
93,979
-4,289
| -4% | -$65.4K | 0.01% | 1513 |
|
|
2015
Q4 | $1.32M | Sell |
98,268
-539
| -0.5% | -$7.25K | 0.01% | 1578 |
|
|
2015
Q3 | $1.39M | Sell |
98,807
-3,500
| -3% | -$49.1K | 0.01% | 1557 |
|
|
2015
Q2 | $1.74M | Buy |
102,307
+2,324
| +2% | +$39.5K | 0.01% | 1525 |
|
|
2015
Q1 | $1.21M | Buy |
99,983
+1,033
| +1% | +$12.5K | ﹤0.01% | 1795 |
|
|
2014
Q4 | $821K | Buy |
98,950
+76,400
| +339% | +$634K | ﹤0.01% | 1913 |
|
|
2014
Q3 | $196K | Buy |
22,550
+234
| +1% | +$2.03K | ﹤0.01% | 2695 |
|
|
2014
Q2 | $244K | Buy |
22,316
+8,466
| +61% | +$92.6K | ﹤0.01% | 2652 |
|
|
2014
Q1 | $124K | Buy |
13,850
+1,672
| +14% | +$15K | ﹤0.01% | 2673 |
|
|
2013
Q4 | $92K | Buy |
12,178
+397
| +3% | +$3K | ﹤0.01% | 2979 |
|
|
2013
Q3 | $86K | Buy |
11,781
+5,048
| +75% | +$36.9K | ﹤0.01% | 2973 |
|
|
2013
Q2 | $43K | Buy |
+6,733
| New | +$43K | ﹤0.01% | 2983 |
|